Shopping Cart
Remove All
Your shopping cart is currently empty
Thalidomide-O-amido-PEG3-C2-NH2 (Cereblon Ligand-Linker Conjugates 3) is an E3 ligase ligand-linker conjugate developed using a Thalidomide-based cereblon ligand and a 3-unit PEG linker, synthesized specifically for use in PROTAC technology.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 100 mg | Inquiry | Backorder | Backorder | |
| 500 mg | Inquiry | Backorder | Backorder |
| Description | Thalidomide-O-amido-PEG3-C2-NH2 (Cereblon Ligand-Linker Conjugates 3) is an E3 ligase ligand-linker conjugate developed using a Thalidomide-based cereblon ligand and a 3-unit PEG linker, synthesized specifically for use in PROTAC technology. |
| In vitro | Thalidomide-O-amido-PEG3-C2-NH2 (Cereblon Ligand-Linker Conjugates 3), comprising a Degron (E3 ubiquitin ligase) and a linker, is employed in PROTAC technology to degrade target proteins like BRD4, BRD2, and BRD3 by binding to the targeting ligand[1]. |
| Synonyms | E3 Ligase Ligand-Linker Conjugates 14, Cereblon Ligand-Linker Conjugates 3 |
| Molecular Weight | 506.51 |
| Formula | C23H30N4O9 |
| Cas No. | 1957236-20-2 |
| Relative Density. | 1.358 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.